Hair Loss on Mounjaro: Causes, Timeline and Practical Steps

Step 1, Recognise what you are actually seeing

Most people who notice hair loss after starting Mounjaro are experiencing telogen effluvium. The hair growth cycle has three phases; the third, telogen, is the resting-and-shedding phase. Any significant physiological stress (rapid caloric reduction, substantial weight change, major illness, surgery) can push a larger-than-normal proportion of follicles into that resting phase simultaneously. Two to four months later, those follicles shed together, which is when the alarming clumps appear on the pillow or in the shower drain.

This pattern is acknowledged in NHS guidance on tirzepatide, which lists hair loss among the side effects that some people experience. Crucially, the evidence points to caloric restriction and rapid weight change as the physiological trigger, not a direct pharmacological action of tirzepatide on the follicle. That is not a reason to dismiss the symptom; it is a reason to understand it correctly so you respond appropriately.

A quick check you can do right now: part your hair and photograph your scalp in good light. Do the same spot in four weeks. Diffuse thinning across the scalp (rather than patchy bald areas or a receding hairline) strongly suggests effluvium rather than another condition, and that observation is worth sharing at your next clinical review.

Step 2, Understand the typical timeline and what affects it

Telogen effluvium is self-limiting for the majority of people. Once the rate of weight loss stabilises or the body adapts to the new intake level, follicles return to their normal growth cycle. In practice, shedding often peaks around months three to five of treatment, then gradually tapers. Most people who experience it notice significant improvement within six months without any change to their prescription.

Several factors can prolong or worsen the shed. Inadequate protein is the most common one our prescribers flag: when appetite drops sharply on tirzepatide, total protein intake can fall below what hair follicles need to stay in the growth phase. Aim for adequate daily protein from eggs, lean meat, dairy, pulses or a supplement, how much is right for your weight depends on your prescriber or a registered dietitian, but the principle is consistent. Iron deficiency is another frequent contributor, particularly in premenopausal women. If shedding seems disproportionate or does not ease by month six, a GP can run a simple blood panel covering ferritin, thyroid function and B12 before attributing everything to effluvium.

For more detail on the physiological reasons hair loss occurs during Mounjaro treatment, our dedicated page covers the biology in full.

Step 3, Take practical action without stopping treatment

Stopping Mounjaro is rarely the right response to mild-to-moderate shedding, and doing so without clinical discussion could mean losing the metabolic and health benefits that prompted the prescription. The more useful steps are nutritional and observational.

On the nutritional side: prioritise protein at every meal, keep iron-rich foods in your diet, and stay hydrated. Biotin supplements are widely discussed online; the evidence base for them in non-deficient adults is thin, but they carry little risk in standard doses. Gentle hair care (reducing heat styling and tight ponytails during the shed period) limits mechanical loss on top of the effluvium.

On the observational side: log the volume of shedding. A rough daily count or a weekly photograph gives your prescriber useful information. If the pattern is stable or improving, the clinical calculus usually favours continuing treatment. If any side effect, including this one, feels unmanageable, that conversation belongs with your prescriber, not with a search engine.

Our prescribers at nume discuss side effects as part of every consultation. Check your eligibility and speak to our clinical team if you have questions about how hair-related side effects would be managed alongside your treatment.

When hair loss needs urgent or prompt medical attention

Telogen effluvium is not dangerous, but other causes of hair loss can be. Get a GP appointment promptly if you notice any of the following: sudden patchy loss or circular bald patches; scalp redness, scaling or itching; loss at the temples or a widening central parting that suggests a different pattern; or hair loss accompanied by fatigue, feeling cold, weight fluctuation or mood changes that could indicate a thyroid problem. These presentations fall outside typical effluvium and need investigation.

Separately, report any suspected adverse effects to the MHRA Yellow Card scheme, this is how the regulator builds a real-world safety picture of medicines like tirzepatide, including Black Triangle (▼) products that carry additional monitoring requirements. You do not need a diagnosis to file a report; a suspicion is enough.

For a broader overview of what clinical reviewers look for when patients raise hair loss during Mounjaro treatment, that page addresses the prescriber's perspective in detail. And if you want to understand whether the evidence supports a direct causal link between the medicine and hair loss, we have examined that question separately. The official side-effect status of hair loss in Mounjaro's licensed documentation is also worth reading before drawing conclusions. Further context on hair loss that begins or continues after stopping Mounjaro is covered on a dedicated page too.